ClinicalTrialsFinder

Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma Clinical Trials in Nanjing, Jiangsu

1 recruitingNanjing, Jiangsu, China

Showing 1–1 of 1 trials

Recruiting
Phase 2

The Study of the Combination of Thiotepa and Pomalidomide for the Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma Patients.

Relapsed or Refractory (R/R) Primary Central Nervous System Lymphoma
The First Affiliated Hospital with Nanjing Medical University28 enrolled1 locationNCT05931328